Stocks · News reference

Ocugen to Present at Upcoming November 2026 Investor Conferences

Oct 29, 2026, 1:03 PM

Ocugen announced it will present on its modifier gene therapy platform at upcoming investor and industry conferences in November 2026, including the Stifel 2026 Healthcare Conference.

More stocks news Connected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

OCGN

Source: fiscal.ai
Observed: Oct 29, 2026, 1:03 PM
Checked: Oct 29, 2026, 1:04 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

Fiscal.aiOct 22, 2026, 9:32 PM
Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4
Ocugen, Inc. announced it will host a conference call and live webcast on November 4, 2026, to discuss its business progress and report financial results for the third quarter of 2026.
OCGN
SEC EDGAROct 15, 2026, 12:01 PMSEC EDGAR
8-K filing — Ocugen, Inc. (OCGN)
Filed: 2026-10-15 AccNo: 0001104659-26-115970 Size: 7 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
OCGN
BenzingaOct 14, 2026, 4:56 PMBenzinga Newsdesk
Ocugen shares are trading lower. The company announced a licensing agreement with Roots Pharmaceutical for exclusive MENA rights to OCU400, its gene therapy for Retinitis Pigmentosa.
OCGN

Ocugen to Present at Upcoming November 2026 Investor Conferences

Connected Markets

Related Headlines

Ocugen to Provide Business Update and Third Quarter 2026 Financial Results on November 4

8-K filing — Ocugen, Inc. (OCGN)

Ocugen shares are trading lower. The company announced a licensing agreement with Roots Pharmaceutical for exclusive MENA rights to OCU400, its gene therapy for Retinitis Pigmentosa.